Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript
…
0,570$
-1,72%
Echtzeit-Aktienkurs Inovio Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Inovio Pharmaceuticals Inc. Aktie
Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript
INO earnings call for the period ending June 30, 2024.…
Inovio Pharmaceuticals: Upcoming BLA Is Critical
…
Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%
The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…
Better Buy: Inovio Pharmaceuticals vs. Novavax
…
Better Buy: Inovio Pharmaceuticals vs. Novavax
Both biotechs have been struggling for a while, but there might be some hope for them.…
Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)
…
Global Oral Transmucosal Drugs Market Size To Exceed USD 62.3 Billion By 2033 | CAGR Of 6.5%
The Global Oral Transmucosal Drugs Market Size was Valued at USD 33.2 Billion in 2023 and the Worldwide Oral Transmucosal…
Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)
…
Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)
…
Oppenheimer maintains price target on Inovio Pharmaceuticals stock By Investing.com
Oppenheimer maintains price target on Inovio Pharmaceuticals stock…
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
INO earnings call for the period ending March 31, 2024.…
Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript
…
Inovio Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Ausblick: Inovio Pharmaceuticals öffnet die Bücher zum abgelaufenen Quartal
Inovio Pharmaceuticals wird am 13.05.2024 das Zahlenwerk zum am 31.03.2024 abgelaufenen Jahresviertel vorstellen.In Sachen EPS gehen 5 Analysten von einem…
Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation
…
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
INO earnings call for the period ending December 31, 2023.…
Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript
…
Antisense and RNAi Therapeutics Market Size & Share Envisaged To Reach USD 18.43 Billion By 2032, at 17.8% CAGR Growth: Polaris Market Research
The global Antisense and RNAi Therapeutics Market size and share is currently valued at USD 4.34 billion in 2023. It…
Inovio Pharmaceuticals, Inc. (INO) CEO Jacque Shea Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference Transcript
…
Inovio Pharmaceuticals Inc. stock outperforms market on strong trading day
Shares of Inovio Pharmaceuticals Inc. rose 8.29% to $0.44 Friday, on what proved to be an all-around mixed trading session…
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript
INO earnings call for the period ending September 30, 2023.…
Inovio Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
…
Inovio Pharmaceuticals, Inc. (INO) Q3 2023 Earnings Call Transcript
…
Active Pharmaceutical Ingredients (API) Market Size to Surpass USD 349.2 Billion Growth by 2030, Exhibit a CAGR of 6.5%
[235 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…
Dextromethorphan Market revenue to reach USD 550 Million by 2035, says Research Nester
Leading dextromethorphan market players include AstraZeneca plc, FibroGen, Inc., Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Merck…
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript
INO earnings call for the period ending June 30, 2023....…
Inovio Pharmaceuticals Inc. Q2 Loss decreases, beats estimates
WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) revealed Loss for second quarter that decreased from last year and beat the…
Form 8-K INOVIO PHARMACEUTICALS, For: Aug 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received…
Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
INOVIO Reports Inducement Grants Under Inducement Plan
PLYMOUTH MEETING, Pa., Aug. 4, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines…
Inovio to shed 30% of staff in restructuring drive
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023
PLYMOUTH MEETING, Pa., July 26, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines…
Form 8-K INOVIO PHARMACEUTICALS, For: Jun 23
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
Plymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) -- INOVIO (NASDAQ:INO) has released the following pursuant to…
Russell 3000 rejig: InMode, Assertio among healthcare additions; Inovio, Bionano among deletions
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
SNDL, Invitae among additions to Russell microcap; Inovio, Bionano among deletions
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers
Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent…
Inovio: EU Grants Orphan Drug Designation For INO-3107
WASHINGTON (dpa-AFX) - Inovio (INO) said that the European Commission granted orphan drug designation for INO-3107, the companys product candidate…
Inovio wins orphan drug status for HPV-related candidate in Europe
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K INOVIO PHARMACEUTICALS, For: May 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
All You Need to Know About Inovio (INO) Rating Upgrade to Buy
Inovio (INO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This…
Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript
INO earnings call for the period ending March 31, 2023....…
Inovio Pharmaceuticals Inc. Q1 Loss decreases, but misses estimates
WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) reported Loss for first quarter that decreased from the same period last year…
INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights
Announced additional positive data from Phase 1/2 trial for INO-3107 in recurrent respiratory papillomatosis patients Second cohort of trial showed…
INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023
PLYMOUTH MEETING, Pa., April 28, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA…
INOVIO: COMP Issues Positive Opinion For Orphan Drug Designation In The EU For INO-3107
WASHINGTON (dpa-AFX) - INOVIO (INO) announced that the European Committee for Orphan Medicinal Products has provided a positive opinion on…
Inovio Presents Data From Phase 1b Trial With INO-4201 As Ebola Booster For RVSV-ZEBOV
WASHINGTON (dpa-AFX) - Inovio (INO) said that data from a Phase 1b trial evaluating INO-4201 as an Ebola booster vaccine…
Why Shares of Inovio Pharmaceuticals Were Down Tuesday
The biotech stock, still reeling from a failed clinical trial, hit a 52-week low....…